21 Stocks Moving in Tuesday's Pre-Market Session

Gainers

• OneSmart International Education Group Limited ONE rose 39.1% to $0.2701 in pre-market trading. OneSmart International Education Group received notification from NYSE regarding delayed Form 20-F filing.
• TSR, Inc. TSRI rose 20.6% to $10.44 in pre-market trading after reporting results for the second quarter.
• Molecular Partners AG MOLN rose 15.3% to $24.78 in pre-market trading. Molecular Partners shares jumped over 30% on Monday after the company, and Novartis, reported topline data from the Phase 2 study for ensovibep, a DARPin antiviral therapeutic for COVID-19.
• Allied Esports Entertainment Inc. AESE shares rose 12.5% to $2.15 in pre-market trading. Allied Esports Entertainment’s 10%+ owner Roy Choi reported purchase of 354,833 shares at an average price of $1.83 per share.
• Accolade, Inc. ACCD rose 10.8% to $21.20 in pre-market trading after the company reported Q3 earnings results and raised FY22 sales guidance.
• TDH Holdings, Inc. PETZ rose 10.8% to $0.8200 in pre-market trading after dipping around 82% on Monday.
• Micro Focus International plc MFGP rose 10.6% to $6.24 in pre-market trading.
• Cellectis S.A. CLLS rose 10.3% to $8.74 in pre-market trading. Cellectis' licensed partner, Allogene Therapeutics, announced removal of FDA clinical hold on their clinical trials.
• Inari Medical, Inc. NARI rose 8.6% to $92.14 in pre-market trading after the company issued strong Q4 and FY21 sales guidance.
• Sonendo, Inc. SONX rose 6.6% to $6.01 in pre-market trading after the company issued strong sales forecast for the fourth quarter.
• Aluminum Corporation of China Limited ACH rose 6.1% to $15.10 in pre-market trading.
• Future FinTech Group Inc. FTFT rose 5.8% to $1.10 in pre-market trading after dropping 10% on Monday. Future FinTech recently named Ola Lind as Chief Strategy Officer.
• Abercrombie & Fitch Co. ANF rose 3.6% to $33.52 in pre-market trading as the company issued an update on its forecast for the 2021 fiscal year. The company said it sees preliminary FY21 net sales rising 19% to 20% from 2020. The company also projects Q4 net sales up in the range of 4% to 6% from 2020.
• Illumina, Inc. ILMN rose 2.5% to $371.37 in pre-market trading as the company issued strong sales forecast for 2022, and also reported four partnership agreements.
• Intel Corporation INTC rose 2.2% to $56.40 in pre-market trading after the company announced leadership changes. Intel reported David Zinsner has been appointed as the company's executive vice president and chief financial officer.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Immunome, Inc. IMNM shares fell 13.7% to $10.00 in pre-market trading after the company announced it received a clinical hold letter from the FDA in response to its recently submitted IND requesting further information.
• Bone Biologics Corporation BBLG shares fell 10.5% to $4.82 in pre-market trading. Bone Biologics shares surged 57% on Monday following the company's presentation at the HC Wainwright BioConnect Virtual Conference..
• Reviva Pharmaceuticals Holdings, Inc. RVPH fell 9.1% to $2.70 in pre-market trading. The FDA, on Monday, notified Reviva Pharmaceuticals that it may proceed with Phase 3 trial of its lead candidate, brilaroxazine, a serotonin and dopamine receptor modulator for schizophrenia.
• Pacific Biosciences of California, Inc. PACB fell 9.1% to $15.08 in pre-market trading.
• Huazhu Group Limited HTHT shares fell 5.6% to $32.66 in pre-market trading after declining around 6% on Monday.
• Biofrontera Inc. BFRI fell 5.3% to $5.93 in pre-market trading after surging 22% on Monday.